Medicina
Département
Hospitais da Universidade de Coimbra
Coímbra, PortugalPublications en collaboration avec des chercheurs de Hospitais da Universidade de Coimbra (12)
2024
-
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
Annals of the Rheumatic Diseases
-
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
Haematologica, Vol. 109, Núm. 1, pp. 115-128
2023
-
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
Movement Disorders, Vol. 38, Núm. 2, pp. 286-303
2022
-
Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry
Leukemia Research, Vol. 115
-
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study
Blood Advances, Vol. 6, Núm. 4, pp. 1278-1295
2021
-
Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors
Intensive and Critical Care Nursing
2015
-
Long-term evolution after in-hospital cardiac arrest in children: Prospective multicenter multinational study
Resuscitation, Vol. 96, pp. 126-134
2014
-
Post return of spontaneous circulation factors associated with mortality in pediatric in-hospital cardiac arrest: A prospective multicenter multinational observational study
Critical Care, Vol. 18, Núm. 6
-
Shockable rhythms and defibrillation during in-hospital pediatric cardiac arrest
Resuscitation, Vol. 85, Núm. 3, pp. 387-391
2013
-
Aspartate aminotransferase to platelet ratio index correlates with hepatic cirrhosis but not with fibrosis in pediatric patients with intestinal failure
Journal of Pediatric Gastroenterology and Nutrition, Vol. 57, Núm. 3, pp. 367-371
2010
-
Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: Results of a multicenter, controlled, randomized, open clinical trial
Clinical Journal of the American Society of Nephrology, Vol. 5, Núm. 7, pp. 1190-1197
2006
-
Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial
Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326